Literature DB >> 17892218

Exploring the complement interaction network using surface plasmon resonance.

Daniel Ricklin1, John D Lambris.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17892218     DOI： 10.1007/978-0-387-71767-8_19

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  9 in total

1.  Allosteric inhibition of complement function by a staphylococcal immune evasion protein.

Authors:  Hui Chen; Daniel Ricklin; Michal Hammel; Brandon L Garcia; William J McWhorter; Georgia Sfyroera; You-Qiang Wu; Apostolia Tzekou; Sheng Li; Brian V Geisbrecht; Virgil L Woods; John D Lambris
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

Review 2.  Complement evasion by human pathogens.

Authors:  John D Lambris; Daniel Ricklin; Brian V Geisbrecht
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

Review 3.  Compstatin: a complement inhibitor on its way to clinical application.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

4.  Electrostatic contributions drive the interaction between Staphylococcus aureus protein Efb-C and its complement target C3d.

Authors:  Nurit Haspel; Daniel Ricklin; Brian V Geisbrecht; Lydia E Kavraki; John D Lambris
Journal:  Protein Sci       Date:  2008-08-07       Impact factor: 6.725

5.  Assessment of Complement Activation by Nanoparticles: Development of a SPR Based Method and Comparison with Current High Throughput Methods.

Authors:  Jean-Baptiste Coty; Magali Noiray; Christine Vauthier
Journal:  Pharm Res       Date:  2018-04-26       Impact factor: 4.200

6.  A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family.

Authors:  Daniel Ricklin; Apostolia Tzekou; Brandon L Garcia; Michal Hammel; William J McWhorter; Georgia Sfyroera; You-Qiang Wu; V Michael Holers; Andrew P Herbert; Paul N Barlow; Brian V Geisbrecht; John D Lambris
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

7.  Structure-kinetic relationship analysis of the therapeutic complement inhibitor compstatin.

Authors:  Paola Magotti; Daniel Ricklin; Hongchang Qu; You-Qiang Wu; Yiannis N Kaznessis; John D Lambris
Journal:  J Mol Recognit       Date:  2009 Nov-Dec       Impact factor: 2.137

8.  Real-time label-free detection of complement activation products in human serum by white light reflectance spectroscopy.

Authors:  Panagiota S Petrou; Daniel Ricklin; Maria Zavali; Ioannis Raptis; Sotirios E Kakabakos; Konstantinos Misiakos; John D Lambris
Journal:  Biosens Bioelectron       Date:  2009-05-03       Impact factor: 10.618

9.  Progress and Trends in Complement Therapeutics.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.